Cancer Research Targets Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bachelder, R. E.
Right arrow Articles by Mercurio, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bachelder, R. E.
Right arrow Articles by Mercurio, A. M.
[Cancer Research 63, 5230-5233, September 1, 2003]
© 2003 American Association for Cancer Research

Advances in Brief

Competing Autocrine Pathways Involving Alternative Neuropilin-1 Ligands Regulate Chemotaxis of Carcinoma Cells1

Robin E. Bachelder2, Elizabeth A. Lipscomb, Xuena Lin, Melissa A. Wendt, Neil H. Chadborn, Britta J. Eickholt and Arthur M. Mercurio

Division of Cancer Biology and Angiogenesis, Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215 [R. E. B., E. A. L., X. L., M. A. W., A. M. M.], and Molecular Neurobiology Group, Medical Research Council Centre for Developmental Biology, King’s College London, London SE1 1UL, United Kingdom [N. H. C., B. J. E.]

Neuropilin-1 (NP1), in conjunction with plexins, promotes axon repulsion by binding to semaphorin 3A (SEMA3A). Although NP1 is expressed in carcinoma cells, its functions have remained elusive, and neither SEMA3A nor plexin expression has been explored in cancer. Here we provide evidence that breast carcinoma cells support an autocrine pathway involving SEMA3A, plexin-A1, and NP1 that impedes their ability to chemotax. Reducing SEMA3A or NP1 expression by RNA interference or inhibiting plexin-A1 signaling enhanced migration. Conversely, expression of constitutively active plexin-A1 impaired chemotaxis. The paradox of how breast carcinoma cells expressing these endogenous chemotaxis inhibitors are able to migrate is explained by their expression of vascular endothelial growth factor (VEGF), a NP1 ligand that competes with SEMA3A for receptor binding. Finally, we establish that the ratio of endogenous VEGF and SEMA3A concentrations in carcinoma cells determines their chemotactic rate. Our findings lead to the surprising conclusion that opposing autocrine loops involving NP1 regulate the chemotaxis of breast carcinoma cells. Moreover, our data indicate a novel autocrine function for VEGF in chemotaxis.




This article has been cited by other articles:


Home page
 J. Cell Sci.Home page
L. Capparuccia and L. Tamagnone
Semaphorin signaling in cancer cells and in cells of the tumor microenvironment - two sides of a coin
J. Cell Sci., June 1, 2009; 122(11): 1723 - 1736.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Bagri, M. Tessier-Lavigne, and R. J. Watts
Neuropilins in Tumor Biology
Clin. Cancer Res., March 15, 2009; 15(6): 1860 - 1864.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Catalano, R. Lazzarini, S. Di Nuzzo, S. Orciari, and A. Procopio
The Plexin-A1 Receptor Activates Vascular Endothelial Growth Factor-Receptor 2 and Nuclear Factor-{kappa}B to Mediate Survival and Anchorage-Independent Growth of Malignant Mesothelioma Cells
Cancer Res., February 15, 2009; 69(4): 1485 - 1493.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Castro-Rivera, S. Ran, R. A. Brekken, and J. D. Minna
Semaphorin 3B Inhibits the Phosphatidylinositol 3-Kinase/Akt Pathway through Neuropilin-1 in Lung and Breast Cancer Cells
Cancer Res., October 15, 2008; 68(20): 8295 - 8303.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
Z. Belaid-Choucair, Y. Lepelletier, G. Poncin, A. Thiry, C. Humblet, M. Maachi, A. Beaulieu, E. Schneider, A. Briquet, P. Mineur, et al.
Human Bone Marrow Adipocytes Block Granulopoiesis Through Neuropilin-1-Induced Granulocyte Colony-Stimulating Factor Inhibition
Stem Cells, June 1, 2008; 26(6): 1556 - 1564.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
C. Rolny, L. Capparuccia, A. Casazza, M. Mazzone, A. Vallario, A. Cignetti, E. Medico, P. Carmeliet, P. M. Comoglio, and L. Tamagnone
The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment
J. Exp. Med., May 12, 2008; 205(5): 1155 - 1171.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. Sulpice, J. Plouet, M. Berge, D. Allanic, G. Tobelem, and T. Merkulova-Rainon
Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity
Blood, February 15, 2008; 111(4): 2036 - 2045.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Chakraborty, S. Jain, and G. C. Kundu
Osteopontin Promotes Vascular Endothelial Growth Factor Dependent Breast Tumor Growth and Angiogenesis via Autocrine and Paracrine Mechanisms
Cancer Res., January 1, 2008; 68(1): 152 - 161.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M.-A. Herve, H. Buteau-Lozano, R. Vassy, I. Bieche, G. Velasco, M. Pla, G. Perret, S. Mourah, and M. Perrot-Applanat
Overexpression of Vascular Endothelial Growth Factor 189 in Breast Cancer Cells Leads to Delayed Tumor Uptake with Dilated Intratumoral Vessels
Am. J. Pathol., January 1, 2008; 172(1): 167 - 178.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T.-M. Hong, Y.-L. Chen, Y.-Y. Wu, A. Yuan, Y.-C. Chao, Y.-C. Chung, M.-H. Wu, S.-C. Yang, S.-H. Pan, J.-Y. Shih, et al.
Targeting Neuropilin 1 as an Antitumor Strategy in Lung Cancer
Clin. Cancer Res., August 15, 2007; 13(16): 4759 - 4768.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Vacca, C. Scavelli, G. Serini, G. Di Pietro, T. Cirulli, F. Merchionne, D. Ribatti, F. Bussolino, D. Guidolin, G. Piaggio, et al.
Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma
Blood, September 1, 2006; 108(5): 1661 - 1667.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Q.-D. Nguyen, S. Rodrigues, C. M. Rodrigue, C. Rivat, C. Grijelmo, E. Bruyneel, S. Emami, S. Attoub, and C. Gespach
Inhibition of vascular endothelial growth factor (VEGF)-165 and semaphorin 3A-mediated cellular invasion and tumor growth by the VEGF signaling inhibitor ZD4190 in human colon cancer cells and xenografts.
Mol. Cancer Ther., August 1, 2006; 5(8): 2070 - 2077.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
L. M. Ellis
The role of neuropilins in cancer
Mol. Cancer Ther., May 1, 2006; 5(5): 1099 - 1107.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Catalano, P. Caprari, S. Moretti, M. Faronato, L. Tamagnone, and A. Procopio
Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function
Blood, April 15, 2006; 107(8): 3321 - 3329.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. J. Gray, J. S. Wey, A. Belcheva, M. F. McCarty, J. G. Trevino, D. B. Evans, L. M. Ellis, and G. E. Gallick
Neuropilin-1 Suppresses Tumorigenic Properties in a Human Pancreatic Adenocarcinoma Cell Line Lacking Neuropilin-1 Coreceptors
Cancer Res., May 1, 2005; 65(9): 3664 - 3670.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Murga, O. Fernandez-Capetillo, and G. Tosato
Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2
Blood, March 1, 2005; 105(5): 1992 - 1999.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. Autiero, F. De Smet, F. Claes, and P. Carmeliet
Role of neural guidance signals in blood vessel navigation
Cardiovasc Res, February 15, 2005; 65(3): 629 - 638.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. Castro-Rivera, S. Ran, P. Thorpe, and J. D. Minna
Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect
PNAS, August 3, 2004; 101(31): 11432 - 11437.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.